Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details)

v3.20.4
Note 5 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Dec. 31, 2020
Jun. 30, 2020
Total assets $ 117,426 $ 124,268
Contingent consideration 10,582 6,137
Derivative instruments - cash flow hedges 12,314 17,331
Total liabilities 22,896 23,468
Fair Value, Inputs, Level 1 [Member]    
Total assets 109,152 116,272
Contingent consideration 0 0
Derivative instruments - cash flow hedges 0 0
Total liabilities 0 0
Fair Value, Inputs, Level 2 [Member]    
Total assets 8,274 7,996
Contingent consideration 0 0
Derivative instruments - cash flow hedges 12,314 17,331
Total liabilities 12,314 17,331
Fair Value, Inputs, Level 3 [Member]    
Total assets 0 0
Contingent consideration 10,582 6,137
Derivative instruments - cash flow hedges 0 0
Total liabilities 10,582 6,137
Equity Securities [Member]    
Investments, Fair Value Disclosure [1] 94,198 87,842
Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]    
Investments, Fair Value Disclosure [1] 85,924 79,846
Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]    
Investments, Fair Value Disclosure [1] 8,274 7,996
Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]    
Investments, Fair Value Disclosure [1] 0 0
Certificates of Deposit [Member]    
Investments, Fair Value Disclosure [2] 23,228 36,426
Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]    
Investments, Fair Value Disclosure [2] 23,228 36,426
Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]    
Investments, Fair Value Disclosure [2] 0 0
Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]    
Investments, Fair Value Disclosure [2] $ 0 $ 0
[1] Included in available-for-sale investments on the balance sheet. The cost basis in the Company's investment in ChemoCentryx Inc (CCXI) at December 31, 2020 and June 30, 2020 was $6.6 million. The Company has a warrant to purchase additional CCXI equity shares which was valued at $8.3 million and $8.0 million as of December 31, 2020 and June 30 2020, respectively.
[2] Included in available-for-sale investments on the balance sheet. The certificate of deposits have contractual maturity dates within one year.